ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $712,500 | -14.4% | 94,496 | +12.3% | 0.02% | -14.8% |
| Q3 2022 | $832,000 | -8.5% | 84,143 | -6.4% | 0.03% | +3.8% |
| Q2 2022 | $909,000 | +8.2% | 89,895 | +4.4% | 0.03% | +52.9% |
| Q1 2022 | $840,000 | -31.1% | 86,123 | +1.2% | 0.02% | -29.2% |
| Q4 2021 | $1,220,000 | -38.4% | 85,105 | -16.4% | 0.02% | -35.1% |
| Q3 2021 | $1,979,000 | +16.3% | 101,764 | +27.2% | 0.04% | +32.1% |
| Q2 2021 | $1,702,000 | -12.2% | 79,972 | +10.1% | 0.03% | -17.6% |
| Q1 2021 | $1,938,000 | – | 72,624 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |